Is Microsoft throttling VR for Xbox?

“When it ships next year we believe it will be the most powerful console ever built,” said Phil Spencer, head of Xbox, adding that Scorpio would offer over six teraflops of power.

”This is the console to lead gaming into true 4k and high-fidelity VR.”

That was Phil Spencer at 2016’s E3, talking about the then just announced Project Scorpio (now revealed as the absurdly named Xbox One X). Yet this year’s Microsoft E3 presentation featured no mention of virtual reality for Xbox and the company in fact seemed rather determined to avoid talking about the possibility. So what has changed to turn Xbox away from VR?

Back in 2016, Xbox seemed determined to step into the VR field and even went so far as to say that a VR version of Fallout 4 (which previewed at this year’s Bethesda conference) would appear on the then still codenamed Project Scorpio. Exactly what they planned was unclear, as there was no mention of headsets at the time, but there were several options in front of the Microsoft team.

Having previously pushed hard about their partnership with Oculus, it would have been reasonable to assume that there would be a Rift attuned specifically to the Xbox One X on the way. Alternatively, with PlayStation having sold over a million units of PSVR, it was possible that Microsoft might try to compete by creating their own console virtual reality headset.

Yet this year, talking to the BBC, Phil Spencer said, “I don’t get many questions about console and mixed reality in the living room. I think there’s just issues with my TVs across the room, there are cables hanging out. When I do this on my PC, I’m closer to my PC, that seems to be a much more user friendly scenario today.”

The U-turn seems… strange. From boasting about the potential The Xbox One X had as a virtual reality machine to determinedly avoiding even saying the words ‘virtual reality’ (throughout the interview with the BBC, Spencer is very deliberate about always saying ‘mixed’ rather than ‘virtual’), it seems like word has come down that Xbox is to avoid even discussing console virtual reality.

Instead, the words mixed reality seem to put the focus on HoloLens, their holographic platform. The oddness here is that HoloLens is by no means a consumer product (the development edition retails at $3,000) and it’s almost certainly not a gaming platform. While they have somewhat more consumer friendly versions made by their original equipment manufacturer (OEM) partners, it still doesn’t really make sense as any sort of analogue for their VR competitors.

Again, Spencer talking to the BBC, “We are believers in mixed reality. Mixed reality on the pc is something we’re focused on and building first party games. Our mixed reality platform with our OEM partners continues to rollout, we’ll have more to talk about in the future.”

Images courtesy of Xbox

It certainly sounds like Spencer has been specifically told not to mention virtual reality in relation to Xbox. The question remains, though: why? You’d think a more standard response would either be that “we’re not working on it right now” or “we may have something in the works but we’re not ready to talk about”, not this weird divert into saying virtual reality doesn’t belong on console.

Whether or not they want to talk about it, console VR is a thing. Microsoft presumably has a plan here but it’s hard to work out what it could be, unless they’re saving some big reveal for another convention down the line. We best hope so because if not, they’re deliberately choosing to throttle their console’s ability to branch out.

Steve “Woz” Wozniak to advise hologram emoji company that he calls “groundbreaking”

Apple’s co-founder Steve “Woz” Wozniak has found himself a new gig; Woz has joined the hologram emoji company, Mojiit, as an adviser.

In his role as advisor to Mojiit, the legendary entrepreneur and engineer will help assemble a world-class engineering team in addition to bringing investors and partnerships to the newly launched startup. Wozniak will also serve as mentor to Mojiit founder, Jeremy Greene.

“I’m thrilled to join Mojiit as an advisor,” said Wozniak. “Jeremy is a natural leader, the company is groundbreaking, it’s going to change the ecommerce space, and it’s a lot of fun.”

Created in 2017, Mojiit is the latest startup technology venture from Greene. The company’s tech essentially enables users to project and share 3D hologram emojis via smartphones.

The platform turns users into emojis by scanning their face, which can then be sent to loved ones and friends. Once a Mojiit message is received, it will map the area where it is received and place the Mojiit hologram there in real time, so it works in a similar way to Pokemon Go.

“Steve is one of the best and brilliant engineers in the entire world. But outside of that, he’s a wonderful man,” said Greene. “There isn’t anyone I’d want to be in business with more than this guy. He’s a legend. Who better to learn from than the guy who created the computer?”

Image courtesy of Nichollas Harrison. Featured image courtesy of Mojiit

In addition to consumer use, businesses of all kinds can tap into hologram emojis with Mojiit’s technology.

Mojiit investors already  include NFL alum Ed Reed, and the company was able to raise a total of $1 million in its seed round of funding.

Alongside the appointment of Woz, Entourage and Ballers producer Rob Weiss recently joined the company as a creative director.

“It’s exciting to expand beyond television and film to digital platforms,” said Weiss. “Hologram technology brings incredible opportunity to entertainment and media. I’m thrilled to be leading creative at Mojiit.”

Nanoengineers send antibiotic-delivering micromotors into the body to treat cancer-causing infection

Nanoengineers have demonstrated for the first time how “micromotors” that measure half the width of a human hair can be used to transport antibiotics through the body.

Nanoengineers at the University of California San Diego tested the micromotors in mice with Helicobacter pylori infections, which can also be found in about two-thirds of the world’s population and while many people will never notice any signs of its presence it can cause peptic ulcers and stomach cancer.

The mice received the micromotors – packed with a clinical dose of the antibiotic clarithromycin – orally once a day for five consecutive days.

Afterwards, nanoengineers evaluated the bacterial count in each mouse stomach and found that treatment with the micromotors was slightly more effective than when the same dose of antibiotic was given in combination with proton pump inhibitors, which also suppress gastric acid production.

Micromotors administered to the mice swam rapidly throughout the stomach while neutralising gastric acid, which can be destructive to orally administered drugs such as antibiotics and protein-based pharmaceuticals.

Because gastric acid is so destructive to traditional antibiotics drugs used to treat bacterial infections, ulcers and other diseases in the stomach are normally taken with additional substances, called proton pump inhibitors.

But when taken over longer periods or in high doses, proton pump inhibitors can cause adverse side effects including headaches, diarrhea and fatigue. In more serious cases, they can cause anxiety or depression.

The micromotors, however, have a built-in mechanism that neutralises gastric acid and effectively deliver their drug payloads in the stomach without requiring the use of proton pump inhibitors.

“It’s a one-step treatment with these micromotors, combining acid neutralisation with therapeutic action,” said Berta Esteban-Fernández de Ávila, a postdoctoral scholar in Wang’s research group at UC San Diego and a co-first author of the paper.

The nanoengineers say that while the present results are promising, this work is still at an early stage.

To test their work, the team is planning future studies to into the therapeutic performance of the micromotors in animals and humans, and will compare it with other standard therapies used to combat stomach diseases.

UC San Diego nanoengineers also plan to test different drug combinations with the micromotors to treat multiple diseases in the stomach or in different sections of the gastrointestinal tract.

Overall, the researchers say that this work opens the door to the use of synthetic motors as active delivery platforms in the treatment of diseases.

Image and video courtesy of the Laboratory for Nanobioelectronics at UC San Diego.